
Correct!
3. Cheyne Stokes Breathing
Explanation: Several  changes associated with sleep result in decrease in arterial oxygen (PaO2) during  sleep. These include loss of behavioral control of ventilation (such as during  speaking and swallowing), decreased responsiveness to hypercapnia and hypoxemia,  reduced functional capacity of the lungs and decreased tidal volume and minute  ventilation (1). Furthermore, there is a decrease in tone of skeletal muscles  including the accessory muscles of respiration and upper airway muscles. Latter  is associated with an increase in upper airway resistance. These effects are  generally more pronounced during REM sleep compared to NREM sleep, leading to  worse oxygenation during this sleep stage. Hence hypoxemia associated with  COPD, pulmonary hypertension or OSA may frequently be worse during REM. 
  
Cheyne-Stokes  respiration with central sleep apnea (CSR-CSA) is characterized by a  waxing-waning pattern of breathing with episodes of hyperventilation  alternating with hypopneas or apneas. While the exact etiology of CSA–CSR is  yet to be clearly elucidated, several factors might contribute to this pattern  of breathing typically described in persons with heart failure (2). Comparing  patients with heart failure with CSA-CSR and those without CSA-CSR reveals that  former is associated with higher pulmonary capillary wedge pressure and  increased central and peripheral chemosensitivity. Both these factors  contribute to stimulation of ventilation, and thence, lower daytime and  sleeping partial pressure of  carbon dioxide in blood (PaCO2). 
  
There is a failure of PaCO2 to increase above apneic threshold during sleep in these patients, which leads to central apneas and rise in PaCO2. However, the enhanced sensitivity of chemeoreceptors to PaCO2 then induces hyperventilation, ventilatory overshoot and hypocapnia, which again is followed by hypoventilation and central apneas. During REM, not only can the hypoventilation relative to NREM sleep lead to increase in the PaCO2 to above the apneic threshold, but the loss in respiratory muscle tone and chemosensitivity leads to dampening of breathing changes associated with changes in PaCO2. This leads to a decrease in the propensity for the cyclical CSR-CSA. This cyclical pattern, hence, is more common in N1 stage than in deeper stages of NREM sleep and REM.
References